ライフサイエンスコーパス: lipoprotein receptor

1 for lipoprotein lipase and very-low-density lipoprotein receptor.

2 oproteinase-9 pathway in pericytes through a lipoprotein receptor.

3 hibits cholesterol uptake by the low-density lipoprotein receptor.

4 regulating neuronal migration by binding to lipoprotein receptors.

5 gnition sequence in the cytoplasmic tails of lipoprotein receptors.

6 ran sulfate proteoglycans (HSPGs) as remnant lipoprotein receptors.

7 2 cm(2)+/-0.023 [n=9], P2X7(-/-) low density lipoprotein receptor(-/-) : 0.084 cm(2)+/-0.01 [n=11], P

8 domain (FIMAC), CD5 domain, and low density lipoprotein receptor 1 (LDLr1) and LDLr2 domains.

9 labeled anti-lectinlike oxidized low-density lipoprotein receptor 1 antibody, which detects the lecti

10 detects the lectinlike oxidized low-density lipoprotein receptor 1 that is overexpressed on a variet

11 Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) is a pattern-recognition

12 Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1), one of the scavenger rec

13 LOX-1 (lectin-like oxidized low-density lipoprotein receptor-1), a membrane protein expressed in

14 These results identify control of lipoprotein receptor abundance by IDOL as a post-transcr

15 Mice deficient for the low-density lipoprotein receptor and Apobec-1 were studied as an age

16 Mice deficient for both the low-density lipoprotein receptor and Apobec-1 were studied at 30 wee

17 CIH down-regulated hepatic low-density lipoprotein receptor and HMG-CoA reductase expression in

18 mice, which are deficient in the low-density lipoprotein receptor and in which hypercholesterolemia i

19 ering, with the discovery of the low-density lipoprotein receptor and its physiology and not only the

20 over, they reveal an unexpected link between lipoprotein receptor and sphingolipid signaling that, in

21 clearance of remnants occurs via low density lipoprotein receptors and the heparan sulfate proteoglyc

22 h a t-PA receptor, most likely a low-density lipoprotein receptor, and a plasminogen receptor.

23 onger Sepp1 isoforms bind to the low density lipoprotein receptor apoER2, but the mechanism remains u

24 DH is caused by mutations in the low-density lipoprotein receptor, apolipoprotein B, or proprotein co

25 Ubiquitous blocking of LRP1 or additional lipoprotein receptors by overexpressing receptor-associa

26 acrophage by modulating oxidized low-density lipoprotein receptor CD36, phagolysosomal maturation blo

27 Genetic deletion of a lipoprotein receptor, CD36, reduces macrophage lipid con

28 that the amino-terminal modular low-density lipoprotein receptor class A (LA) domains within HP14 ar

29 -coenzyme A reductase, and human low-density lipoprotein receptor), compared to uninfected controls.

30 d aorta in atherosclerosis-prone low-density lipoprotein receptor deficient (Ldlr(-/-)) mice.

31 cted deletion of DNGR-1 in Ldlr (low-density lipoprotein receptor)-deficient mice (Ldlr(-/-)) signifi

32 Low-density lipoprotein receptor-deficient (Ldlr(-/-) ) mice were cr

33 c lesions from high-fat diet-fed low-density lipoprotein receptor-deficient (Ldlr(-/-)) mice in a tim

34 radiated, atherosclerosis-prone, low-density lipoprotein receptor-deficient (Ldlr(-/-)) mice received

35 Male low-density lipoprotein receptor-deficient (Ldlr(-/-)) mice were mai

36 t cells in atherosclerosis-prone low-density lipoprotein receptor-deficient (Ldlr(-/-)) mice, we show

37 and spleens of high-fat diet-fed low-density lipoprotein receptor-deficient (Ldlr(-/-)) mice.

38 n atherosclerosis was studied in low density lipoprotein receptor-deficient (Ldlr(-/-)) mice.

39 cells in atherosclerosis-prone, low-density lipoprotein receptor-deficient (Ldlr(-/-)) mice.

40 nvading photoreceptors: the very low-density lipoprotein receptor-deficient (Vldlr(-/-) ) mouse.

41 were crossed into hyperlipidemic low-density lipoprotein receptor-deficient animals.

42 In a low-density lipoprotein receptor-deficient atherosclerotic mouse mod

43 Herein, in low-density lipoprotein receptor-deficient hyperlipidemic and strept

44 Low-density lipoprotein receptor-deficient LDLr(-/-) mice were fed a

45 hways have been shown to protect low-density lipoprotein receptor-deficient mice (Ldlr(-/-)) from ear

46 f diet-induced insulin-resistant low-density lipoprotein receptor-deficient mice and of genetically o

47 d reduced steatosis in livers of low-density lipoprotein receptor-deficient mice fed a Western diet.

48 ecreased hepatic inflammation in low-density lipoprotein receptor-deficient mice on a Western-type di

49 e response pathways in livers of low-density lipoprotein receptor-deficient mice on a Western-type di

50 evelopment of atherosclerosis in low-density lipoprotein receptor-deficient mice.

51 the AngII-infused hyperlipidemic low-density lipoprotein receptor-deficient mouse (LDLR(-/-)) model,

52 and insulin resistance in mice, low-density lipoprotein receptor-deficient, S100A9-deficient bone ma

53 o regulate IDOL expression and IDOL-mediated lipoprotein receptor degradation.

54 exin type 9 (PCSK9) binds to the low-density lipoprotein receptor, escorting it to its destruction in

55 onarily conserved pathway for the control of lipoprotein receptor expression and cellular lipid uptak

56 ing protein 2 and downregulating low-density lipoprotein receptor expression.

57 tein 1 (LRP1) is a member of the low density lipoprotein receptor family and plays important roles in

58 -AP-2 and directs endocytosis of low density lipoprotein receptor family members by recognizing a pho

59 perone that binds LRP1 and other low density lipoprotein receptor family members in the endoplasmic r

60 eptor (VLDLR) is a member of the low-density lipoprotein receptor family that binds multiple ligands

61 liposomes utilize scavenger and low-density lipoprotein receptors for endocytosis and enter cells th

62 Lipoprotein receptors have broad effects in both the dev

63 aising the expression of SREBP2, low-density lipoprotein receptor, HMGCo-A reductase, and the cholest

64 A significant role is established for lipoprotein receptors in sprouting and regeneration afte

65 tilisin kexin 9 (PCSK9) binds to low-density lipoprotein receptors, increasing serum LDL-C.

66 models of C57BL/6 wild-type and low density lipoprotein receptor knock-out (LDLR(-/-)) mice.

67 R/KR) mice are intercrossed with low density lipoprotein receptor knock-out mice (Ldlr(-/-)), they de

68 Cholesterol-fed low-density lipoprotein receptor knockout (LDLR(-/-)) mice were trea

69 nd 31%, respectively, in fasting low-density lipoprotein receptor knockout (LDLR(-/-)) mice.

70 ipoprotein cholesterol (LDLc) in low density lipoprotein receptor knockout (LDLR(-/-)) mice.

71 ECGs were measured in low-density lipoprotein receptor knockout (LDLr(-/-)), apolipoprotei

72 d PB-NLCs were investigated in a low density lipoprotein receptor knockout (LDLr-/-) mouse model, inc

73 n- (OVA-) sensitized C57BL/6 and low-density lipoprotein receptor knockout mice (LDLr(-/-)) for 5 wee

74 nesis by mPGES-1 deletion in the low-density lipoprotein receptor knockout mice (n=17-21).

75 In this study, we fed low-density lipoprotein receptor knockout mice a Western high-fat di

76 ve transfer of apop(ox)-DCs into low-density lipoprotein receptor knockout mice either before or duri

77 te T cell lipid composition and responses in lipoprotein receptor knockout mice even in the absence o

78 r leakage in the eyecups of very low-density lipoprotein receptor knockout mice, a model of subretina

79 erosclerotic lesion formation in low-density lipoprotein receptor knockout mice.

80 herosclerosis development in the low-density lipoprotein receptor knockout mouse.

81 on a hyperlipidemic background (low-density lipoprotein receptor knockouts).

82 were crossed into hyperlipidemic low-density lipoprotein receptor knockouts.

83 ts an atheroprotective action on low density lipoprotein receptor (LDL-r(-/-)) female mice, but, in c

84 Investigation on the role of low-density lipoprotein receptor (LDL-R) as a hepatocyte surface rec

85 ulates surface expression of the low-density lipoprotein receptor (LDL-R), increasing serum LDL-C.

86 planted into lethally irradiated low density lipoprotein receptor Ldlr(-/-) mice on an atherogenic di

87 bit recognition of oxLDL by KCs, low-density lipoprotein receptor (Ldlr(-/-) ) mice were immunized wi

88 to mice that do not express the low density lipoprotein receptor (Ldlr(-/-)), which are hyperlipidem

89 a Western-type diet and lacking low-density lipoprotein receptor (Ldlr(-/-)T39(-/-)) show decreased

90 oss-of-function mutations in the low-density lipoprotein receptor (LDLR) and homozygous familial hype

91 PCSK9 binds to the low density lipoprotein receptor (LDLR) and leads to LDLR degradatio

92 owth factor-like-A domain of the low density lipoprotein receptor (LDLR) and mediates LDLR degradatio

93 ct of the treatments on cellular low-density lipoprotein receptor (LDLR) and proprotein convertase su

94 lly deficient iPSC utilizing the low-density lipoprotein receptor (LDLR) deficiency Familial Hypercho

95 Female low-density lipoprotein receptor (Ldlr) deficient mice with an XX or

96 ficiently blocked PCSK9-mediated low density lipoprotein receptor (LDLR) degradation in cell lines, i

97 n and receptors belonging to the low density lipoprotein receptor (LDLR) family, known to be involved

98 ive conformations for binding to low-density lipoprotein receptor (LDLR) family.

99 a patient with mutations in the low-density lipoprotein receptor (LDLR) gene that result in familial

100 e polymorphism in exon 12 of the low-density lipoprotein receptor (LDLR) gene, rs688, has been associ

101 thionine beta-synthase (CBS) and low-density lipoprotein receptor (LDLr) genes were deficient (Ldlr(-

102 rol and an overexpression of the low-density lipoprotein receptor (LDLR) in pancreatic tumor cells.

103 Low-density lipoprotein receptor (LDLR) internalization clears chole

104 The low-density lipoprotein receptor (LDLR) is a critical determinant of

105 e recently demonstrated that the low-density lipoprotein receptor (LDLR) is a major apoE receptor in

106 Therefore, the low-density lipoprotein receptor (LDLR) is a relevant target for del

107 The low density lipoprotein receptor (LDLR) is crucial for cholesterol h

108 Low-density lipoprotein receptor (LDLR) is involved in uptake of cho

109 osclerotic lesion macrophages of low-density lipoprotein receptor (Ldlr) knockout mice fed a Western

110 k3a/GSK3alpha-knockout mice with low-density lipoprotein receptor (Ldlr) knockout mice.

111 atients who already have reduced low-density lipoprotein receptor (LDLR) levels, such as those with h

112 regulation through modulation of low density lipoprotein receptor (LDLR) levels.

113 The hepatic low-density lipoprotein receptor (LDLR) pathway is essential for cle

114 The low-density lipoprotein receptor (LDLR) plays a pivotal role in clea

115 Low-density lipoprotein receptor (LDLR) rs6511720 A was significantl

116 Since the low-density lipoprotein receptor (LDLR) was recently identified as a

117 Low density lipoprotein receptor (LDLR) was shown to mediate clearan

118 te that modulating levels of the low-density lipoprotein receptor (LDLR), a cell surface receptor tha

119 ruits its cargoes, including the low-density lipoprotein receptor (LDLR), and mediates endocytosis, e

120 At low-density lipoprotein receptor (LDLR), carriers of rare non-synony

121 f the identified substrates, the low-density lipoprotein receptor (LDLR), ERdj5 is required not for d

122 N1), Occludin (OCLN), SR-BI, and low-density lipoprotein receptor (LDLR), function mainly at postatta

123 adhesion molecule-1 (ICAM-1) and low-density lipoprotein receptor (LDLR), inter- and intraspecies foo

124 fied 2 nonsynonymous variants in low-density lipoprotein receptor (LDLR), namely p.G116S and p.R730W.

125 eptor molecules CD81, claudin-1, low-density lipoprotein receptor (LDLr), occludin, and SR-BI did not

126 lisin/kexin type 9 (PCSK9) binds low-density lipoprotein receptor (LDLR), preventing its recycling.

127 of-of-principle, we targeted the low-density lipoprotein receptor (Ldlr), which when deleted, leads t

128 poprotein E (apoE)-deficient and low-density lipoprotein receptor (LDLR)-deficient mice that produce

129 sly demonstrated that macrophage low-density lipoprotein receptor (LDLR)-related protein 1 (LRP1) def

130 osine-protein kinase), and Lrp4 (low-density lipoprotein receptor (LDLR)-related protein 4), an LDLR

131 and regulate its activity on the low-density lipoprotein receptor (LDLR).

132 oss-of-function mutations in the low-density lipoprotein receptor (LDLR).

133 LDL (low-density lipoprotein) receptor (LDLR) binds to its negative regul

134 a IDOL and inducible degrader of low-density lipoprotein receptor [LDLR]), with LDL cholesterol stati

135 a mechanism that is dependent on low-density lipoprotein receptors (LDLRs) and LDLR-related protein 1

136 clathrin-mediated endocytosis of low-density lipoprotein receptors (LDLRs).

137 concomitant with an increase in low density lipoprotein receptors (LDLRs).

138 PCSK9 levels, increased hepatic low-density lipoprotein receptor levels, and decreased plasma choles

139 y showed that SERPINA3K binds to low-density lipoprotein receptor-like protein 6 (LRP6) with a K(d) o

140 The lipoprotein receptor LRP1 is essential in neurons of the

141 Low-density lipoprotein receptors (LRPs) are present extensively on

142 The lipolysis-stimulated lipoprotein receptor (LSR) is the host cell receptor for

143 Here, we show that Lipolysis-stimulated lipoprotein receptor (LSR), a component of paracellular

144 ILDR1 was recently reported to be a lipoprotein receptor mediating the secretion of the fat-

145 s analyzed in aortic arches from low density lipoprotein receptor(-/-) mice consuming a high-choleste

146 P2X7(+/+) and P2X7(-/-) low density lipoprotein receptor(-/-) mice were fed a high-cholester

147 lanted into irradiated recipient low-density lipoprotein receptor(-/-) mice, and atherosclerosis was

148 Very low-density lipoprotein receptor mutant mice (Vldlr(-/-)) exhibit cr

149 rotein-deficient (apoE(-/-)) and low-density lipoprotein receptor negative (LDLR(-/-)) mice (0.05 mmo

150 Low-density lipoprotein receptor null mice in which Treg express gre

151 DS AND Paradoxically, Ldlr(-/-) (low-density lipoprotein receptor null) mice deficient in miR-146a de

152 ion size was found in Ldlr(-/-) (low-density lipoprotein receptor null) mice transplanted with bone m

153 ed atherosclerosis in irradiated low-density lipoprotein receptor null-recipient mice and in apolipop

154 Low density lipoprotein receptor-null (Ldlr(-/-)) mice on a high-fat

155 experimental atherosclerosis in low-density lipoprotein receptor-null mice (Ldlr(-/-)).

156 Cre-IKKbeta-flox system rendered low density lipoprotein receptor-null mice resistant to vascular inf

157 ar smooth muscle lineage of male low-density lipoprotein receptor-null mice, a background susceptible

158 fied alpha2M delivers its misfolded cargo to lipoprotein receptors on macrophages and reduces Abeta1-

159 harboring targeting motifs from low-density lipoprotein receptor or neuron-glia cell-adhesion molecu

160 ermeability, whereas blockade of low-density lipoprotein receptors or exposed lysine residues resulte

161 rest to address drugs and contrast agents to lipoprotein-receptor-overexpressing cancer cells found i

162 ver provided that an intact apoE-low-density lipoprotein receptor pathway is present.

163 arizes our current understanding of the role lipoprotein receptors play in CNS function and AD pathol

164 In parallel, the low-density-lipoprotein receptor plays a predominant role in the cle

165 Low-density lipoprotein receptor protein 1 exerts antiatherogenic ef

166 d dramatic reductions in hepatic low-density lipoprotein receptor protein and increased plasma low-de

167 n/kexin type 9 (PCSK9) regulates low density lipoprotein receptor protein levels by diverting it to l

168 veloped in these mice, LDLR(-/-)/low-density lipoprotein receptor Rag 1 double-knockout mice (lacking

169 In LDLR(-/-)/low-density lipoprotein receptor Rag 1 double-knockout mice, sustain

170 This points to macLRP1 being the only lipoprotein receptor regulating VWF levels.

171 in the liver can override other low-density lipoprotein receptor regulatory pathways leading to card

172 d pGSK-3beta(Ser9), unchanged pPDK1, pTau or lipoprotein receptor related protein 1 (LRP1), higher gl

173 mation involves Frizzled4 (Fz4), low-density lipoprotein receptor related protein 5/6 (Lrp5/6), Tetra

174 ed the phosphorylation of the Wnt coreceptor lipoprotein receptor related protein 6 (LRP6) and induce

175 nalization of Abeta bound to the low density lipoprotein receptor related protein-1, a key Abeta clea

176 1/2), to their cognate receptor, low-density-lipoprotein-receptor related protein 6 (LRP6), in the pl

177 distinct receptors, namely, the low-density lipoprotein receptor-related protein (LRP) and cell surf

178 Enhanced expression of low-density lipoprotein receptor-related protein (LRP) in brain micr

179 healthy donors was decreased after blocking lipoprotein receptor-related protein (LRP), a CRT recept

180 ously reported that RanBP9 binds low-density lipoprotein receptor-related protein (LRP), amyloid prec

181 pids, von Willebrand factor, and low-density lipoprotein receptor-related protein (LRP).

182 Low density lipoprotein receptor-related protein (LRP1) mediates the

183 mber of the LDL receptor family, low-density lipoprotein receptor-related protein (LRP1).

184 Low-density lipoprotein receptor-related protein 1 (LRP-1) is a scav

185 Blocking low-density lipoprotein receptor-related protein 1 (LRP-1) receptor

186 We achieve this by targeting the Low Density Lipoprotein Receptor-Related Protein 1 (LRP-1) receptor.

187 MTS-5 is rapidly endocytosed via low density lipoprotein receptor-related protein 1 (LRP1) and degrad

188 ors for these secreted proteins, low-density lipoprotein receptor-related protein 1 (LRP1) and Integr

189 6535, located within intron 1 of low-density-lipoprotein receptor-related protein 1 (LRP1) demonstrat

190 clearance and signaling receptor low density lipoprotein receptor-related protein 1 (LRP1) in both pr

191 trated significant roles for the low-density lipoprotein receptor-related protein 1 (LRP1) in the met

192 The low density lipoprotein receptor-related protein 1 (LRP1) is a membe

193 The low density lipoprotein receptor-related protein 1 (LRP1) is a ubiqu

194 Low density lipoprotein receptor-related protein 1 (LRP1) is indispe

195 Low-density lipoprotein receptor-related protein 1 (LRP1) regulates

196 Blocking studies of low-density lipoprotein receptor-related protein 1 (LRP1) suggested

197 lso requires the function of the low-density lipoprotein receptor-related protein 1 (LRP1), a major a

198 associated with its reduction in low-density lipoprotein receptor-related protein 1 (LRP1), an Abeta

199 d both alpha2M and its receptor, low-density lipoprotein receptor-related protein 1 (LRP1), in cultur

200 An Abeta clearance receptor, the low-density lipoprotein receptor-related protein 1 (LRP1), is abunda

201 apoE and sAbeta compete for the low-density lipoprotein receptor-related protein 1 (LRP1)-dependent

202 arance by the scavenger receptor low density lipoprotein receptor-related protein 1 (LRP1).

203 he endocytic scavenger receptor, low-density lipoprotein receptor-related protein 1 (LRP1).

204 ecific interactions of apoE with low-density lipoprotein receptor-related protein 1 on brain vascular

205 uptake was partially due to the low-density lipoprotein receptor-related protein 1.

206 s mRNA and protein expression of low density lipoprotein receptor-related protein 2 and alpha-synucle

207 ts with SNMG were retrospectively tested for lipoprotein receptor-related protein 4 (LRP4) antibodies

208 ain was impaired in mice lacking low-density lipoprotein receptor-related protein 4 (Lrp4), a protein

209 dentified autoantibodies against low-density lipoprotein receptor-related protein 4 (LRP4), an agrin

210 euromuscular synapses, and (iii) low-density lipoprotein receptor-related protein 4 (Lrp4), which res

211 ein acting downstream from agrin/low-density lipoprotein receptor-related protein 4 (LRP4)/MuSK, has

212 tified previously in vitro LRP4 (low-density lipoprotein receptor-related protein 4) as a facilitator

213 tein, which interacts with LRP4 (low-density lipoprotein receptor-related protein 4) to activate the

214 dentified novel functions of the low-density lipoprotein receptor-related protein 4-muscle-specific k

215 acid position (p.R1188W) in the low density lipoprotein receptor-related protein 5 (LRP5) gene segre

216 g ligand or receptors, including low-density lipoprotein receptor-related protein 5 (LRP5) gene.

217 yptophan hydroxylase 1 (Tph1) or low-density lipoprotein receptor-related protein 5 (Lrp5) that are i

218 eton is affected by mutations in low-density lipoprotein receptor-related protein 5 (LRP5).

219 mice in which a mutation in the low-density lipoprotein receptor-related protein 5 Wnt coreceptor ca

220 d the Wnt-activated Frizzled and low-density lipoprotein receptor-related protein 5/6 receptors and p

221 it binds to the Wnt co-receptor low-density lipoprotein receptor-related protein 6 (LRP6) in cellula

222 contributions of Wnt coreceptor low-density lipoprotein receptor-related protein 6 (LRP6) in the vas

223 Low-density lipoprotein receptor-related protein 6 (LRP6) is a Wnt c

224 The low-density lipoprotein receptor-related protein 6 (LRP6) is an esse

225 induced by a constitutively active mutant of lipoprotein receptor-related protein 6 (LRP6) or beta-ca

226 Interactions between Cav-1 and low-density lipoprotein receptor-related protein 6 (LRP6) were repor

227 Additionally, inhibition of low-density lipoprotein receptor-related protein 6 (LRP6) with eithe

228 is gene 2, as well as coreceptor low density lipoprotein receptor-related protein 6 (LRP6), are marke

229 including the expression of the Wnt receptor-lipoprotein receptor-related protein 6 (LRP6), phosphory

230 and Wnt3a and the Wnt coreceptor low-density lipoprotein receptor-related protein 6 (LRP6), possibly

231 s a ternary complex with the Wnt co-receptor Lipoprotein receptor-related protein 6 (LRP6).

232 chaperone for the Wnt coreceptor low-density lipoprotein receptor-related protein 6 (LRP6).

233 lin-dependent internalization of low-density lipoprotein receptor-related protein 6 (LRP6).

234 g pathway by down-regulating the low-density lipoprotein receptor-related protein 6 (LRP6).

235 by binding to the Wnt coreceptor low-density lipoprotein receptor-related protein 6 (LRP6).

236 ch as frizzled homolog 7 (FZD7), low density lipoprotein receptor-related protein 6 and transcription

237 he E1E2 domain of Wnt coreceptor low-density lipoprotein receptor-related protein 6, Mab2F1, on canon

238 Fetal liver cells derived from low-density-lipoprotein receptor-related protein 6-deficient mice (L

239 e encoding WNT receptors (frizzled [FZD] and lipoprotein receptor-related protein [LRP] family member

240 pse number were mediated via the low-density lipoprotein receptor-related protein and subsequent Ca(2

241 (ADAM9), reticulon 4 (RTN4), and low-density lipoprotein receptor-related protein associated protein

242 ociated protein (an inhibitor of low density lipoprotein receptor-related protein function) and requi

243 The low-density lipoprotein receptor-related protein receptors 1 and 2 (

244 tutions within LRP1B, encoding a low-density lipoprotein receptor-related protein tied to both the NM

245 on of eNOS was decreased by anti-low density lipoprotein receptor-related protein-1 (LRP) antibody an

246 ound that the endocytic receptor low density lipoprotein receptor-related protein-1 (LRP-1) plays a m

247 The relationship between low-density lipoprotein receptor-related protein-1 (LRP1) and von Wi

248 We recently identified low density lipoprotein receptor-related protein-1 (LRP1) as a novel

249 s including mannose receptor and low-density lipoprotein receptor-related protein-1 (LRP1) have been

250 scular hypothesis, impairment of low-density lipoprotein receptor-related protein-1 (LRP1) in brain c

251 Low-density lipoprotein receptor-related protein-1 (LRP1) is a large

252 Low-density lipoprotein receptor-related protein-1 (LRP1) is an endo

253 The low density lipoprotein receptor-related protein-1 (LRP1) is known t

254 giopep-2 (ANG), a ligand for the low-density lipoprotein receptor-related protein-1 (LRP1), has also

255 vation of beta1 integrin via the low density lipoprotein receptor-related protein-1 (LRP1), which lea

256 s dependent on the transmembrane low density lipoprotein receptor-related protein-1 (LRP1).

257 mbospondin-1 (TSP1) and synaptic low-density lipoprotein receptor-related protein-1 (LRP1).

258 pathway that apparently requires low-density lipoprotein receptor-related protein-1 (LRP1).

259 mbospondin-1 (TSP1) and synaptic low-density lipoprotein receptor-related protein-1 (LRP1).

260 Soluble low density lipoprotein receptor-related protein-1 (sLRP1) binds ~70

261 PDE1C interacts with low-density lipoprotein receptor-related protein-1 and PDGFRbeta, th

262 exin domain of MMP9 binds to the low-density lipoprotein receptor-related protein-1, triggers phospho

263 some-dependent degradation in an low-density lipoprotein receptor-related protein-1-dependent manner.

264 DGFRbeta protein degradation via low-density lipoprotein receptor-related protein-1.

265 hat Wnt receptors (Frizzled4 and low-density lipoprotein receptor-related protein5 [Lrp5]) and activi

266 igand-binding antagonist for the low-density lipoprotein receptor-related proteins (LRPs), and siRNA-

267 a ligand for the WNT coreceptors low-density lipoprotein receptor-related proteins 5 and 6 (LRP-5 and

268 hese results complement our understanding of lipoprotein receptor-related proteins 5 and 6 (LRP5/6),

269 izzled 1-10 and the co-receptors low-density lipoprotein receptor-related proteins 5 and 6.

270 eceptor (FZD) and the coreceptor low-density lipoprotein-receptor-related protein 5 (LRP5).

271 how that the soluble form of the low-density lipoprotein receptor relative, LR11/SorLA (sLR11), suppr

272 rotein E receptor 2 and the very low density lipoprotein receptor, resulting in the phosphorylation o

273 ion, and function of the murine high density lipoprotein receptor scavenger receptor class B type I (

274 itellogenin receptor Yolkless, a low density lipoprotein receptor superfamily member, occur; a functi

275 FERM domain, membrane phospholipids, and the lipoprotein receptor tail.

276 B type 1), encoded by the gene SCARB1, is a lipoprotein receptor that binds both high-density lipopr

277 also known as SorLA, is a mosaic low-density lipoprotein receptor that exerts multiple influences on

278 Class B scavenger receptors (SR-B) are lipoprotein receptors that also mediate pathogen recogni

279 BI (SR-BI) and BII (SR-BII) are high-density lipoprotein receptors that recognize various pathogens,

280 th the RELN receptor VLDLR (very low-density lipoprotein receptor); this was confirmed by a RELN-bind

281 odies prevent the degradation of low density lipoprotein receptor, thus lowering serum levels of LDL-

282 venting the recirculation of the low-density lipoprotein receptor to the hepatocyte cell surface.

283 a 95-141) that separates the two low-density lipoprotein receptor type A (LDLR-A) domains does not af

284 Reelin signals via the lipoprotein receptors very low density lipoprotein recep

285 Activation of very low density lipoprotein receptor (VLDLR) and apolipoprotein E recept

286 a the lipoprotein receptors very low density lipoprotein receptor (VLDLR) and apolipoprotein E recept

287 n E receptor 2 (ApoER2) and very low density lipoprotein receptor (VLDLR) and is internalized by cell

288 d that miR-200c targets the very low density lipoprotein receptor (Vldlr) and its ligand reelin, whic

289 Receptor 2 (ApoER2) and the very low density lipoprotein receptor (VLDLR) are type I transmembrane pr

290 mutation, c.2239C>T, in the very-low-density lipoprotein receptor (Vldlr) gene.

291 The very low density lipoprotein receptor (VLDLR) is a member of the low-dens

292 viously, we have shown that very low density lipoprotein receptor (VLDLR) is virtually absent in prea

293 The very-low-density lipoprotein receptor (VLDLR) negatively regulates Wnt si

294 ding through the receptors, Very low-density lipoprotein receptor (Vldlr), Apolipoprotein receptor 2

295 in another Reelin receptor, very low-density lipoprotein receptor (VLDLR), had normal rod bipolar mor

296 Very-low-density lipoprotein receptor (Vldlr), which is present in photor

297 another angiogenic model of very-low-density lipoprotein receptor (Vldlr)-deficient (Vldlr (-/-) ) mi

298 neovascularization and the very low density lipoprotein receptor (Vldlr)-knockout mouse].

299 apparent effect of hypoxia on HSPGs, whereas lipoprotein receptors (VLDLR and SR-B1) were transiently

300 an interaction with VLDLR (very low-density lipoprotein receptor), while the APOER2 signaling pathwa